LH Labcorp
NYSE · SEC CIK 920148 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $13.70M 20 sales by 10 insiders
- Filings on record
- 414 since 2021-08-03, latest 2026-09-03 08:21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| Parham Richelle P | Dir | — | $1.78M |
| Wilkinson Peter J | SVP, CAO | — | $1.06M |
| ANDERSON KERRII B | Dir | — | $954.1K |
| Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| Summy Amy B. | EVP, CMO | — | $283.4K |
| Kyle Kathryn W | EVP, CLO | — | $227.4K |
| van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
Transactions 566
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-10 | 2025-02-06 | LH | NEUPERT PETER M | Dir | M - OptEx | — | +944 | 12.9K | +8% | — |
| D | 2025-02-10 | 2025-02-06 | LH | Gilliland Dwight Gary | Dir | M - OptEx | — | +944 | 8,656 | +12% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +7,710 | 91.9K | +9% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $246.98 | -2,585 | 90.7K | -3% | -$638.4K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +1,299 | 28.8K | +5% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $247.06 | -394 | 29.0K | -1% | -$97.3K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | — | +267 | 2,220 | +14% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $247.00 | -92 | 2,262 | -4% | -$22.7K |
| 2025-01-08 | 2025-01-07 | LH | ANDERSON KERRII B | Dir | S - Sale | $235.00 | -1,000 | 12.7K | -7% | -$235.0K | |
| 2024-12-04 | 2024-12-02 | LH | Gilliland Dwight Gary | Dir | S - Sale | $241.00 | -1,000 | 7,712 | -11% | -$241.0K | |
| DM | 2024-12-04 | 2024-12-02 | LH | EISENBERG GLENN A | EVP | M - OptEx | $212.21 | +11.7K | 43.0K | +37% | +$2.49M |
| D | 2024-12-04 | 2024-12-02 | LH | EISENBERG GLENN A | EVP | S - Sale+OE | $240.43 | -11.7K | 31.3K | -27% | -$2.82M |
| D | 2024-11-26 | 2024-11-22 | LH | Summy Amy B. | EVP, CMO | S - Sale+OE | $238.91 | -3,672 | 4,318 | -46% | -$877.2K |
| D | 2024-11-26 | 2024-11-22 | LH | Summy Amy B. | EVP, CMO | M - OptEx | $168.52 | +4,015 | 7,990 | +101% | +$676.6K |
| 2024-11-25 | 2024-11-21 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale | $239.42 | -1,000 | 2,670 | -27% | -$239.4K | |
| 2024-11-13 | 2024-11-11 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale | $243.47 | -6,189 | 87.4K | -7% | -$1.51M | |
| 2024-10-25 | 2024-10-24 | LH | ANDERSON KERRII B | Dir | S - Sale | $230.00 | -1,000 | 13.7K | -7% | -$230.0K | |
| 2024-08-21 | 2024-08-19 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale | $227.05 | -2,000 | 3,670 | -35% | -$454.1K | |
| M | 2024-08-19 | 2024-08-15 | LH | EISENBERG GLENN A | CFO, EVP | S - Sale | $223.99 | -15.0K | 31.3K | -32% | -$3.36M |
| M | 2024-08-09 | 2024-08-07+ | LH | ANDERSON KERRII B | Dir | S - Sale | $225.00 | -1,000 | 15.3K | -6% | -$225.0K |
| M | 2024-08-07 | 2024-08-05 | LH | BERBERIAN LANCE | EVP, CIO, CTO | S - Sale | $229.11 | -12.1K | 15.9K | -43% | -$2.77M |
| D | 2024-06-10 | 2024-06-06 | LH | Rothman Paul | Dir | M - OptEx | — | +717 | 717 | New | — |
| M | 2024-05-16 | 2024-05-14 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale | $210.83 | -2,000 | 5,837 | -26% | -$421.7K |
| D | 2024-05-02 | 2024-04-30 | LH | EISENBERG GLENN A | CFO, EVP | F - Tax | $201.37 | -4,496 | 46.3K | -9% | -$905.4K |
| D | 2024-05-02 | 2024-04-30 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | — | +10.2K | 50.8K | +25% | — |
| M | 2024-05-02 | 2024-04-30+ | LH | ANDERSON KERRII B | Dir | S - Sale | $202.12 | -500 | 15.7K | -3% | -$101.1K |
| 2024-05-01 | 2024-04-29 | LH | Wilkinson Peter J | SVP, CAO | S - Sale | $204.33 | -2,439 | 2,087 | -54% | -$498.4K | |
| D | 2024-04-17 | 2024-04-15 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | — | +10.2K | 45.1K | +29% | — |
| D | 2024-04-17 | 2024-04-15 | LH | EISENBERG GLENN A | CFO, EVP | F - Tax | $203.32 | -4,496 | 40.6K | -10% | -$914.1K |
| 2024-04-03 | 2024-04-01 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale | $217.29 | -6,477 | 5,036 | -56% | -$1.41M | |
| D | 2024-04-03 | 2024-04-01 | LH | Bailey Megan D. | EVP, Chief Strategy Off | M - OptEx | — | +205 | 505 | +68% | — |
| D | 2024-04-03 | 2024-04-01 | LH | Bailey Megan D. | EVP, Chief Strategy Off | F - Tax | $216.35 | -69 | 436 | -14% | -$14.9K |
| 2024-04-03 | 2024-04-01 | LH | Summy Amy B. | EVP, CMO | S - Sale | $217.29 | -3,500 | 3,975 | -47% | -$760.5K | |
| D | 2024-03-29 | 2024-03-28 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $216.74 | -3,553 | 7,637 | -32% | -$770.1K |
| D | 2024-03-29 | 2024-03-27 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +6,158 | 13.8K | +81% | — |
| D | 2024-03-29 | 2024-03-27 | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $216.57 | -2,605 | 11.2K | -19% | -$564.2K |
| D | 2024-03-29 | 2024-03-27 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $216.57 | -5,079 | 11.5K | -31% | -$1.10M |
| D | 2024-03-29 | 2024-03-27 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +11.6K | 16.6K | +229% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +72.4K | 125.4K | +137% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $216.57 | -31.8K | 93.6K | -25% | -$6.89M |
| D | 2024-03-29 | 2024-03-27 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | — | +20.0K | 43.6K | +85% | — |
| D | 2024-03-29 | 2024-03-27 | LH | EISENBERG GLENN A | CFO, EVP | F - Tax | $216.57 | -8,805 | 34.8K | -20% | -$1.91M |
| D | 2024-03-29 | 2024-03-27 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | — | +3,079 | 5,420 | +132% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $216.57 | -894 | 4,526 | -16% | -$193.6K |
| D | 2024-03-29 | 2024-03-27 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +11.6K | 32.9K | +54% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $216.57 | -5,061 | 27.9K | -15% | -$1.10M |
| D | 2024-03-29 | 2024-03-27 | LH | DiVincenzo Jonathan P. | EVP, Pres, Central Labs, Intl | F - Tax | $216.57 | -952 | 5,461 | -15% | -$206.2K |
| D | 2024-03-29 | 2024-03-27 | LH | DiVincenzo Jonathan P. | EVP, Pres, Central Labs, Intl | M - OptEx | — | +3,012 | 6,413 | +89% | — |
| D | 2024-03-29 | 2024-03-27 | LH | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +7,697 | 31.3K | +33% | — |
| D | 2024-03-29 | 2024-03-27 | LH | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $216.57 | -3,299 | 28.0K | -11% | -$714.5K |
| D | 2024-03-29 | 2024-03-27 | LH | Summy Amy B. | EVP, CMO | M - OptEx | — | +5,778 | 9,637 | +150% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Summy Amy B. | EVP, CMO | F - Tax | $216.57 | -2,162 | 7,475 | -22% | -$468.2K |
| D | 2024-03-11 | 2024-03-07 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale+OE | $218.45 | -5,048 | 5,036 | -50% | -$1.10M |
| D | 2024-03-11 | 2024-03-07 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $117.09 | +2,119 | 10.1K | +27% | +$248.1K |
| 2024-03-11 | 2024-03-07 | LH | Summy Amy B. | EVP, CMO | S - Sale | $218.45 | -227 | 3,859 | -6% | -$49.6K | |
| D | 2024-02-22 | 2024-02-21 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | $163.63 | +14.1K | 58.1K | +32% | +$2.30M |
| DM | 2024-02-22 | 2024-02-21 | LH | EISENBERG GLENN A | CFO, EVP | S - Sale+OE | $215.97 | -34.5K | 39.7K | -46% | -$7.45M |
| 2024-02-22 | 2024-02-21 | LH | DiVincenzo Jonathan P. | EVP, Pres, Central Labs, Intl | S - Sale | $215.49 | -500 | 3,401 | -13% | -$107.7K | |
| 2024-02-15 | 2024-02-13 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale | $226.45 | -237 | 7,637 | -3% | -$53.7K | |
| D | 2024-02-13 | 2024-02-11 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +472 | 8,091 | +6% | — |
| D | 2024-02-13 | 2024-02-12 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $227.45 | -126 | 7,965 | -2% | -$28.7K |
| D | 2024-02-13 | 2024-02-12 | LH | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $227.45 | -87 | 23.6K | -0.4% | -$19.8K |
| D | 2024-02-13 | 2024-02-11 | LH | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +324 | 23.7K | +1% | — |
| D | 2024-02-13 | 2024-02-12 | LH | EISENBERG GLENN A | CFO, EVP | F - Tax | $227.45 | -215 | 44.0K | -0.5% | -$48.9K |
| D | 2024-02-13 | 2024-02-11 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | — | +807 | 44.3K | +2% | — |
| D | 2024-02-13 | 2024-02-11 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | — | +123 | 2,384 | +5% | — |
| D | 2024-02-13 | 2024-02-12 | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $227.45 | -43 | 2,341 | -2% | -$9,780 |
| D | 2024-02-13 | 2024-02-11 | LH | DiVincenzo Jonathan P. | EVP, Pres, Central Labs, Intl | M - OptEx | — | +201 | 3,960 | +5% | — |
| D | 2024-02-13 | 2024-02-12 | LH | DiVincenzo Jonathan P. | EVP, Pres, Central Labs, Intl | F - Tax | $227.45 | -59 | 3,901 | -1% | -$13.4K |
| D | 2024-02-13 | 2024-02-12 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $227.45 | -137 | 21.4K | -0.6% | -$31.2K |
| D | 2024-02-13 | 2024-02-11 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +472 | 21.5K | +2% | — |
| D | 2024-02-13 | 2024-02-12 | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $227.45 | -87 | 7,874 | -1% | -$19.8K |
| D | 2024-02-13 | 2024-02-11 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +324 | 7,961 | +4% | — |
| D | 2024-02-13 | 2024-02-12 | LH | Summy Amy B. | EVP, CMO | F - Tax | $227.45 | -66 | 4,086 | -2% | -$15.0K |
| D | 2024-02-13 | 2024-02-11 | LH | Summy Amy B. | EVP, CMO | M - OptEx | — | +201 | 4,152 | +5% | — |
| D | 2024-02-13 | 2024-02-12 | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $227.45 | -1,231 | 53.0K | -2% | -$280.0K |
| D | 2024-02-13 | 2024-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,964 | 54.2K | +6% | — |
| 2024-02-09 | 2024-02-08 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale | $222.06 | -259 | 7,637 | -3% | -$57.5K | |
| D | 2024-02-08 | 2024-02-07 | LH | Kong Garheng | Dir | M - OptEx | — | +947 | 11.9K | +9% | — |
| D | 2024-02-08 | 2024-02-07 | LH | NEUPERT PETER M | Dir | M - OptEx | — | +947 | 11.9K | +9% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Gilliland Dwight Gary | Dir | M - OptEx | — | +947 | 8,712 | +12% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Davis Jeffrey A. | Dir | M - OptEx | — | +947 | 3,619 | +35% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $223.71 | -46 | 2,261 | -2% | -$10.3K |
| D | 2024-02-08 | 2024-02-07 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | — | +134 | 2,307 | +6% | — |
| D | 2024-02-08 | 2024-02-07 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +353 | 7,990 | +5% | — |
| D | 2024-02-08 | 2024-02-07 | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $223.71 | -94 | 7,896 | -1% | -$21.0K |
| D | 2024-02-08 | 2024-02-07 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | — | +885 | 43.7K | +2% | — |
| D | 2024-02-08 | 2024-02-07 | LH | EISENBERG GLENN A | CFO, EVP | F - Tax | $223.71 | -236 | 43.5K | -0.5% | -$52.8K |
| DM | 2024-02-08 | 2024-02-07 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $223.71 | -204 | 21.1K | -1.0% | -$45.6K |
| DM | 2024-02-08 | 2024-02-07 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +629 | 21.1K | +3% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Kliphouse Kirsten Marie | Dir | M - OptEx | — | +947 | 1,319 | +255% | — |
| D | 2024-02-08 | 2024-02-07 | LH | ANDERSON KERRII B | Dir | M - OptEx | — | +947 | 16.2K | +6% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Wengel Kathryn E | Dir | M - OptEx | — | +947 | 2,292 | +70% | — |
| D | 2024-02-08 | 2024-02-07 | LH | BELINGARD JEAN-LUC | Dir | M - OptEx | — | +947 | 17.9K | +6% | — |
| D | 2024-02-08 | 2024-02-07 | LH | BELINGARD JEAN-LUC | Dir | F - Tax | $223.71 | -95 | 17.8K | -0.5% | -$21.3K |
| D | 2024-02-08 | 2024-02-07 | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $223.71 | -1,149 | 51.3K | -2% | -$257.0K |
| D | 2024-02-08 | 2024-02-07 | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +3,250 | 52.4K | +7% | — |
| DM | 2024-02-08 | 2024-02-07 | LH | Bailey Megan D. | EVP, Chief Strategy Off | M - OptEx | — | +291 | 346 | +529% | — |
| DM | 2024-02-08 | 2024-02-07 | LH | Bailey Megan D. | EVP, Chief Strategy Off | F - Tax | $223.71 | -113 | 300 | -27% | -$25.3K |
| D | 2024-02-08 | 2024-02-07 | LH | Parham Richelle P | Dir | M - OptEx | — | +947 | 8,534 | +12% | — |
Purchase Sale Sale after option exercise All abbreviations